NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Active specific immunotherapy is a promising field in cancer research. N-glycolyl (NGc) gangliosides, and particularly NGcGM3, have received attention as a privileged target for cancer therapy. Many clinical trials have been performed with the anti-NGc-containing gangliosides anti-idiotype monoclona...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fernandez, Luis E., Gabri, Mariano R., Guthmann, Marcelo D., Gomez, Roberto E., Gold, Silvia, Fainboim, Leonardo, Gomez, Daniel E., Alonso, Daniel F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi Publishing Corporation 2010
Schlagworte:
Review Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2965427/
https://ncbi.nlm.nih.gov/pubmed/21048926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/814397
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge